2024-05-12 03:24:07 ET
Cytek Biosciences, Inc. (CTKB)
Q1 2024 Earnings Conference Call
May 08, 2024, 04:30 PM ET
Company Participants
Paul Goodson - Investor Relations
Wenbin Jiang - Chief Executive Officer
William McCombe - Chief Financial Officer
Conference Call Participants
Tejas Savant - Morgan Stanley
Jake Siewert - Goldman Sachs
David Westenberg - Piper Sandler
Noah Krozel - Raymond James
Mason Carrico - Stephens
Jacqueline Kisa - TD Cowen
Presentation
Operator
Thank you for standing by. My name is Liz, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. [Operator Instructions]
I would now like to turn the call over to Paul Goodson, Investor Relations. Please go ahead.
Paul Goodson
Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended March 31, 2024. If you haven't received this news release, or if you'd like to be added to the company's distribution list, please send an email to investors@cytekbio.com. Joining me today from Cytek are Wenbin Jiang, CEO; and newly appointed CFO, Bill McCombe.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding Cytek's business plans, strategies, opportunities and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated....
Read the full article on Seeking Alpha
For further details see:
Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript